methyl 1,4-dihydro-4,4-dimethyl-1-pyridinepentanoate | 115932-99-5

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: methyl 1,4-dihydro-4,4-dimethyl-1-pyridinepentanoate
• 英文别名: Methyl 5-(4,4-dimethylpyridin-1-yl)pentanoate
• CAS: 115932-99-5
• 化学式: C₁₃H₂₁NO₂
• 分子量: 223.315
• InChiKey: CYDKOISFKUESMX-UHFFFAOYSA-N

物化性质

• 沸点：
  303.0±42.0 °C(predicted)
• 密度：
  0.972±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  16
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.62
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  5-氨基颉草酸 在 盐酸 、 molecular sieve 、 三乙胺 作用下， 以 氯仿 为溶剂， 反应 38.0h， 生成 methyl 1,4-dihydro-4,4-dimethyl-1-pyridinepentanoate
  参考文献：
  名称：

  Antihypertensive dihydropyridines with 1,4,4-trisubstitution

  摘要：

  Dihydropyridines with 1,4,4-trisubstitution were synthesized and tested for antihypertensive activity in a spontaneously hypertensive rat model. This substitution pattern on the dihydropyridine nucleus differs markedly from that found most active in the structure-activity relationship established for nifedipine-like compounds. However, some were found to significantly lower blood pressure at testing doses (30 mg/kg, ip and 100 mg/kg, po) for up to 24 h. Methyl 1,4-dihydro-4,4-dimethyl-1-pyridinepropanoate (2-1), for example, lowered blood pressure 71 mmHg at 30 mg/kg, ip and the effect endured for greater than 24 h. Unlike prototypical dihydropyridines such as nifedipine, these compounds did not seem to have any effect on calcium channels.

  DOI：

  10.1021/jm00163a037

文献信息

• US4742068A
  申请人：——

  公开号：US4742068A

  公开（公告）日：1988-05-03
• Antihypertensive dihydropyridines with 1,4,4-trisubstitution
  作者：Michael J. Kukla、Henry J. Breslin、Alan Gill

  DOI：10.1021/jm00163a037

  日期：1990.1

  Dihydropyridines with 1,4,4-trisubstitution were synthesized and tested for antihypertensive activity in a spontaneously hypertensive rat model. This substitution pattern on the dihydropyridine nucleus differs markedly from that found most active in the structure-activity relationship established for nifedipine-like compounds. However, some were found to significantly lower blood pressure at testing doses (30 mg/kg, ip and 100 mg/kg, po) for up to 24 h. Methyl 1,4-dihydro-4,4-dimethyl-1-pyridinepropanoate (2-1), for example, lowered blood pressure 71 mmHg at 30 mg/kg, ip and the effect endured for greater than 24 h. Unlike prototypical dihydropyridines such as nifedipine, these compounds did not seem to have any effect on calcium channels.